Last reviewed · How we verify
Dose 1 of Aluminum Adjuvant
Dose 1 of Aluminum Adjuvant is a Biologic drug developed by Novavax. It is currently in Phase 2 development.
At a glance
| Generic name | Dose 1 of Aluminum Adjuvant |
|---|---|
| Sponsor | Novavax |
| Modality | Biologic |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- An Efficacy, Safety, and Immunogenicity Study of CHIKV VLP Vaccine for the Prevention of Chikungunya Disease in Adolescents and Adults (PHASE3)
- Evaluating the Safety and Immunogenicity of Stabilized CH505 TF chTrimer in Healthy, HIV-uninfected Adult Participants. (PHASE1)
- A Study on the Safety and Immune Response of AS37 Together With Hepatitis B Antigen in Adults Aged 18-45 Years (PHASE1)
- Opportunistic Pneumococcal Immunisation Trial in MALnutrition (PHASE4)
- Safety and Immunogenicity of Recombinant Pichia Pastoris AMA1-DiCo Candidate Malaria Vaccine With GLA-SE and Alhydrogel ® as Adjuvant in Healthy Malaria Non-Exposed European and Malaria Exposed African Adults (PHASE1)
- Clinical Trial to Evaluate the Safety and Immunogenicity of a Priming Regimen of 426c.Mod.Core-C4b Followed by HxB2.WT.Core-C4b Boosts, Both Adjuvanted With 3M-052 AF + Alum, in Adult Participants Without HIV and in Overall Good Health (PHASE1)
- A Clinical Study to Evaluate an Experimental Universal Influenza Vaccine, INFLUENZA G1 mHA, in Healthy Adults (PHASE1, PHASE2)
- Study to Evaluate the Safety, Tolerability and Immunogenicity of Three Doses of GBS Vaccine in Elderly Participants (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Dose 1 of Aluminum Adjuvant CI brief — competitive landscape report
- Dose 1 of Aluminum Adjuvant updates RSS · CI watch RSS
- Novavax portfolio CI
Frequently asked questions about Dose 1 of Aluminum Adjuvant
What is Dose 1 of Aluminum Adjuvant?
Dose 1 of Aluminum Adjuvant is a Biologic drug developed by Novavax.
Who makes Dose 1 of Aluminum Adjuvant?
Dose 1 of Aluminum Adjuvant is developed by Novavax (see full Novavax pipeline at /company/novavax).
What development phase is Dose 1 of Aluminum Adjuvant in?
Dose 1 of Aluminum Adjuvant is in Phase 2.
Related
- Manufacturer: Novavax — full pipeline